This is not a play, merely an investment. If you know about RTI, you'd be interested to know that they have started to generate revenue this year. Glued to $14 support, with the industry gathering momentum, I dare to invest here. I'm not expecting any explosive moves, but I believe in upside for this asset. ACB owns a large portion of RTI's shares.
No reason for RTI to look for lower regions, but in anticipation of the first generated revenue, no reason to look for higher highs either. At some point, one would expect an announcement of how much Aurora will be paying for the implementation of Radient patented technology in its facilities, and Radient should announce being open for business. There is still a...
RTI gapped up on news of it obtaining a standard processing license, then dipped down, almost closing the gap until follow up news broke that RTI is now operational and starts to generate revenue. She broke clear of the $1 level, though she may of course consolidate below it again. Increased bull volume, however, tells me investors are aware of RTI's potential in...
Radient just recently published its results for Q1. With the newly granted license, this company can now, for the first time, start to generate revenue. Looking at its financials, I think they are in an extremely good position. The $1 is a traditionally tough resistance for penny stocks to break. It is at this very level that RTI is trying to break back into its...
ACB is likely going to acquire CMED & HIP , and become the largest LP in the world. For what ever reason, i feel like ACB will just keep on climbing. Many new investors just entering the sector now. Let the bidding wars continue in this speculation driven market.